Status:
UNKNOWN
Quantitative MRI and Outcomes of Liver Resection
Lead Sponsor:
University Hospital Heidelberg
Collaborating Sponsors:
Fundacao Champalimaud
Conditions:
Liver Cancer
Liver Failure
Eligibility:
All Genders
18+ years
Brief Summary
The present observational study aims to assess the benefit of this quantitative multiparametric magnetic resonance imaging (MRI) in clinical practice, to quantify future liver remnant performance, and...
Detailed Description
In patients being considered for major liver resection, volumetric and functional evaluation of the future liver remnant should ideally be combined to reduce the risk of posthepatectomy liver failure ...
Eligibility Criteria
Inclusion
- Adult (≥ 18 years old) patients with an indication for elective major liver resection.
- Any benign or malignant indication.
- Provision of informed consent.
- MRI scan performed ≤ 7 days before surgery
Exclusion
- Previous liver resection.
- Previous volume-enhancing procedures, such as portal vein embolization.
- Previous microwave ablation of liver lesions.
- Contraindication and/or inability to undergo contrast-enhanced MRI scan (including implanted metallic devices or foreign bodies, claustrophobia and contraindication for Primovist® administration).
Key Trial Info
Start Date :
February 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2025
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT06181318
Start Date
February 1 2024
End Date
April 30 2025
Last Update
December 26 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.